Despite the substantial influence of IDH-mutations on the DNA methylation pattern, PMMRDIA were clearly distinguished by DNA methylation profiling from other IDH-mutant gliomas including secondary MMR-deficient tumors which argues for a distinctive cell of origin or an early divergence during oncogenesis. Here, IDH2 is linked to central nervous system cancer.